INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AstraZeneca
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In AstraZeneca To Contact Him Directly To Discuss Their Options NE...
J&J lung cancer treatment extends lives versus AstraZeneca drug
Johnson & Johnson (NYSE:JNJ) has said its chemotherapy-free combination extended lung cancer patients' lives compared to AstraZeneca PLC (LSE:AZN)'s Tagrisso drug in a head-to-head study. The combi...
AstraZeneca pipeline undervalued and underrated, broker suggests
AstraZeneca PLC (LSE:AZN) decline has gone too far, according to the analysts at Berenberg, who note that attention in 2025 switches to the breast cancer, hypertension and obesity pipelines. Curren...
AZN INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that AstraZeneca PLC Investors with Substantial Losses Have Opportunity to Lead Cla...
SAN DIEGO--(BUSINESS WIRE)--The suit alleges defendants issued false statements concerning Astrazeneca business and prospects, resulting in its stock trading at inflated prices.
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 21, 2025 in AstraZeneca Lawsuit - AZN
NEW YORK , Jan. 7, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in AstraZeneca PLC ("AstraZeneca" or the "Company") (NASDAQ: AZN) of a class action securities lawsuit. CLASS DEFINI...
Stockholder Notice: Robbins LLP Informs Stockholders of the AstraZeneca PLC Class Action Lawsuit
SAN DIEGO , Jan. 6, 2025 /PRNewswire/ -- Robbins LLP informs investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired AstraZeneca PLC (NASD...
AstraZeneca (AZN) Reels from China Investigation and Investor Suit– Hagens Berman
SAN FRANCISCO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- AstraZeneca (NASDAQ: AZN), the Anglo-Swedish pharmaceutical giant, has seen its stock price tumble 15 percent over the past six months, buffeted by ...
ROSEN, THE FIRST FILING FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Fil...
NEW YORK, Jan. 06, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of AstraZeneca PLC (NASDAQ: AZN) between February 23, 2022 and D...
AstraZeneca PLC Is Being Sued For Securities Law Violations And The Schall Law Firm Urges Impacted Shareholders To Reach Out
LOS ANGELES, CA / ACCESSWIRE / January 6, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against AstraZeneca PLC ("AstraZenec...
AZN Investors Have Opportunity to Lead AstraZeneca PLC Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES , Jan. 6, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against AstraZeneca PLC ("AstraZeneca" or...
AZN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that AstraZeneca PLC Investors with Substantial Losses Have Opportunity to Lead Cla...
NEW YORK--(BUSINESS WIRE)---- $AZN #AstraZeneca--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been ...
AstraZeneca PLC Sued for Securities Law Violations - Contact Levi & Korsinsky Before February 21, 2025 to Discuss Your Rights - AZN
NEW YORK, NY / ACCESSWIRE / January 5, 2025 / If you suffered a loss on your AstraZeneca PLC (NASDAQ:AZN) investment and want to learn about a potential recovery under the federal securities laws, ...
Investors With Losses Are Invited To Join The Schall Law Firm In A Securities Fraud Case Against AstraZeneca PLC
LOS ANGELES, CA / ACCESSWIRE / January 5, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against AstraZeneca PLC ("AstraZenec...
AstraZeneca PLC Is Being Sued For Securities Law Violations And The Schall Law Firm Urges Affected Shareholders To Reach Out
LOS ANGELES, CA / ACCESSWIRE / January 4, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against AstraZeneca PLC ("AstraZenec...
Better Buy: Novo Nordisk vs. AstraZeneca
Novo Nordisk (NVO 0.15%) and AstraZeneca (AZN 0.56%) are among the largest companies in the pharmaceutical industry. Both have generally produced strong financial results in 2024, but one wouldn't ...
Related Companies